Feb 28 (Reuters) - Creso Pharma Ltd (CPH) :
- FY LOSS FROM ORDINARY ACTIVITIES ATTRIBUTABLE A$32.8 MILLION VERSUS LOSS A$30.0 MILLION
- FY REVENUE FROM ORDINARY ACTIVITIES A$8.7 MILLION, UP 39.7%
News: CPH Creso Pharma Reports FY Loss From Ordinary Activities Attributable A$32.8 Mln
Add to My Watchlist
What is My Watchlist?